EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

OLIDIAG Study: Extra Virgin Olive Oil Supplementation in the Diet of Women with Gestational Diabetes Mellitus—A Randomized Clinical Trial

Alicia Jawerbaum iD, Silvia Gorban de Lapertosa iD, Magdalena Rey, Inés Argerich, Mariano Reynoso iD, María Celeste Muntaner, Celina Bertona, Verónica Kojdamanian Favetto, Esteban Díaz, Stella Sucani, Dalmiro Gomez Ribot iD

Nutrients · 2026

DOI: 10.3390/nu18071120 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Alicia Jawerbaum und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Reproduction and Metabolism, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y …. Hauptthemen laut MEDLINE: Diabetes, Gestational, Dietary Supplements, Olive Oil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Argentine Society of Diabetes, Agencia Nacional de Promoción Científica y Tecnológica de Argentina, Agencia Nacional de Promoción Científica y Tecnológica de Argentina https://ror.org/03stxzb56.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gestational diabetes mellitus (GDM) is a prevalent metabolic disease associated with maternal and neonatal complications. Diets enriched with extra virgin olive oil may benefit metabolism and provide antioxidant effects. We aimed to evaluate the effects of dietary supplementation with extra virgin olive oil on metabolic parameters and insulinization rate in women with GDM.

Methods

This is a multicenter, parallel, randomized controlled trial in which 190 patients with GDM were enrolled before week 29 of gestation and randomized into the Control group and the Intervention group. Patients in the Intervention group received the indication to consume three tablespoons of extra virgin olive oil (EVOO) daily. At term, metabolic parameters, insulin requirement and maternal and neonatal outcomes were evaluated.

Results

Control and Intervention groups showed no differences in maternal age (31.7 ± 6.0 and 32.4 ± 5.2 years, respectively) or gestational age (26.5 ± 3.6 and 26.7 ± 3.3 weeks, respectively) at enrollment. Primary outcomes showed that EVOO consumption was associated with a reduction in insulin requirement (RR 0.595, 95% CI 0.361–0.967, p < 0.05). There was a significant reduction in triglyceridemia in the EVOO-supplemented group compared to controls (MD −43.3 mg/dL, 95% CI −66.8–−19.8, p < 0.01). There were no effects of the intervention on gestational weight gain. As secondary outcomes, maternal BMI and gestational age at delivery showed no changes between the groups. Although maternal and neonatal composite outcomes were not significantly reduced, the rate of neonates with more than one complication (RR 0.340, 95% CI 0.133–0.870, p < 0.05) and NICU requirement (RR 0.367, 95% CI 0.140–0.939, p < 0.05) were significantly reduced in the Intervention group.

Conclusions

In GDM, maternal dietary supplementation with extra virgin olive oil resulted in reduction in maternal triglyceridemia, need of insulinization and neonatal complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalDietary SupplementsOlive OilAdultFemaleHumansInfant, NewbornPregnancyBlood GlucoseInsulinTriglycerides

Stichwörter der Autor:innen

dietary interventionextra virgin olive oilgestational diabetes mellitusinsulin requirementmaternal–neonatal outcomesperinatal complicationstriglyceridemia

Substanzen

Blood GlucoseInsulinOlive OilTriglycerides

Autor:innen und Institutionen

  • Laboratory of Reproduction and Metabolism, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Medicina, Universidad de Buenos Aires…
  • Centro de Investigaciones Farmacológicas, Facultad de Medicina, Universidad Nacional del Nordeste, Corrientes 3400, Argentina.
  • Hospital Alemán, Ciudad Autónoma de Buenos Aires 1118, Argentina.
  • Hospital Perrupato, Mendoza 5570, Argentina.
  • Cátedra de Biología Celular y Molecular, Departamento de Ciencias Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires (UBA), Ciudad Autónoma de Buenos Aires 1113, Argentina.
  • Unidad Patagónica de Medicina Materno Fetal y Embarazo de Alto Riesgo, Neuquén 8300, Argentina.

ORCID-Profile: Alicia Jawerbaum, Silvia Gorban de Lapertosa, Mariano Reynoso, Dalmiro Gomez Ribot

Förderung

  • Argentine Society of Diabetes
  • Agencia Nacional de Promoción Científica y Tecnológica de Argentina
  • Agencia Nacional de Promoción Científica y Tecnológica de Argentina https://ror.org/03stxzb56

Zitieren

APA

Jawerbaum, A., Gorban de Lapertosa, S., Rey, M., Argerich, I., Reynoso, M., Muntaner, M. C., Bertona, C., Favetto, V. K., Díaz, E., Sucani, S., & Gomez Ribot, D. (2026). OLIDIAG Study: Extra Virgin Olive Oil Supplementation in the Diet of Women with Gestational Diabetes Mellitus—A Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu18071120

Vancouver

Jawerbaum A, Gorban de Lapertosa S, Rey M, Argerich I, Reynoso M, Muntaner MC, et al. OLIDIAG Study: Extra Virgin Olive Oil Supplementation in the Diet of Women with Gestational Diabetes Mellitus—A Randomized Clinical Trial. Nutrients. 2026. doi:10.3390/nu18071120

BibTeX
@article{Jawerbaum2026,
  author = {Jawerbaum, Alicia and Gorban de Lapertosa, Silvia and Rey, Magdalena and Argerich, Inés and Reynoso, Mariano and Muntaner, María Celeste and Bertona, Celina and Favetto, Verónica Kojdamanian and Díaz, Esteban and Sucani, Stella and Gomez Ribot, Dalmiro},
  title = {OLIDIAG Study: Extra Virgin Olive Oil Supplementation in the Diet of Women with Gestational Diabetes Mellitus—A Randomized Clinical Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18071120}
}
Kostenlos starten →